Both in Pharmaceuticals
Serina Therapeutics vs Elicio Therapeutics
Over the past year SER returned −66.0% and ELTX returned −80.3%; their daily moves had a correlation of -0.02.
SER −66.0% ELTX −80.3%Growth of $1, one year, split-adjusted
| Metric | SER | ELTX |
|---|---|---|
| Price | $1.76 | $1.94 |
| Market cap | $44.7M | $52.6M |
| Today | −0.56% | +16.17% |
| 1 month | −19.6% | +3.7% |
| 6 months | −9.3% | −83.6% |
| Year to date | −8.0% | −75.6% |
| 1 year | −64.1% | −79.5% |
| Revenue growth (YoY) | −100.0% | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $19.9M | $13.9M |
| Dividend yield | — | — |
| Volatility (60d) | 72.6% | 66.6% |
| Short % of float | 0.8% | 19.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).